1003-3734
2010 Issue 20
Preparation of vinorelbine bitartrate liposomes by triethylammonium sucrose octasulfate gradient method
HUANG Wei-wei1;LI Zhe1;ZHANG Xiao-fei1;ZHANG Ling2;DENG Yi-hui1
HUANG Wei-wei1;LI Zhe1;ZHANG Xiao-fei1;ZHANG Ling2;DENG Yi-hui1
..............page:1903-1906
..............page:1821
Study on preparation of sinomenine microemulsion and its transdermal character
LIU Peng1;GUI Shuang-ying1;2;3;LU Chuan-hua1;3;PENG Dai-yin2;3;QI Xue-ping1;PAN En-yuan1;CHENG Bin1;KAI Wei-hua1
LIU Peng1;GUI Shuang-ying1;2;3;LU Chuan-hua1;3;PENG Dai-yin2;3;QI Xue-ping1;PAN En-yuan1;CHENG Bin1;KAI Wei-hua1
..............page:1911-1914,1920
Efficiency and toxicity of radiotherapy combined with weekly nedaplatin in the treatment of locally advanced nasopharyngeal carcinoma
SHU Zhong-qin;MAO Wei-dong;XIA Lin-yun;LIN Feng
SHU Zhong-qin;MAO Wei-dong;XIA Lin-yun;LIN Feng
..............page:1875-1878
Efficacy of pericarpium trichosanthis injection on stable angina in patients complicated with type 2 diabetes mellitus
ZHAO Ran-zun;SHI Bei;WANG Dong-mei;XU Guan-xue
ZHAO Ran-zun;SHI Bei;WANG Dong-mei;XU Guan-xue
..............page:1871-1874,1884
Effect of recombined pig uricase on the blood concentration of uric acid in chickens and the antigenicity
KUANG Hong-yan1;CHENG Tai-ping2;KOU Wen-e3;CAO Zheng3;RONG Jun3
KUANG Hong-yan1;CHENG Tai-ping2;KOU Wen-e3;CAO Zheng3;RONG Jun3
..............page:1890-1894
Anaphylactoid reactions of 7 traditional Chinese medicine injections in Beagle dogs
YAN Wei-juan1;2;LI Lian-da2;ZHANG Mei-yu2;LI Yi-kui2
YAN Wei-juan1;2;LI Lian-da2;ZHANG Mei-yu2;LI Yi-kui2
..............page:1895-1898,1910
Preparation of selegiline transdermal patch and its release evaluation in vitro
SHEN Ming-le1;WANG Gang2;LI Jian-cheng2;WAN Cheng-tang2;LIU Wan-feng2;CHEN Jian-bing2
SHEN Ming-le1;WANG Gang2;LI Jian-cheng2;WAN Cheng-tang2;LIU Wan-feng2;CHEN Jian-bing2
..............page:1907-1910
The use of bronchodilators in the treatment of airway obstruction in elderly patients
GUO Yan-fei;SUN Tie-ying
GUO Yan-fei;SUN Tie-ying
..............page:1859-1865
..............page:1830-1840
Advance in the research of cationic liposome carriers for gene delivery
YANG Shuo-ye;CHEN Xi-jing
YANG Shuo-ye;CHEN Xi-jing
..............page:1866-1870
..............page:1823-1824
Effect of Niaoduqing on the expression of TGF β-activated kinase 1 and fibronectin in rats with renal tubulointerstitial fibrosis
LIU Ming-long;LU Shou-yan;LI Yan
LIU Ming-long;LU Shou-yan;LI Yan
..............page:1885-1889
Reversal effect of potassium dehydroand rograpolide succinate on the resistance to cisplatin in COC1/DDP cells
LIU Ming-hua;ZHANG Zhuo;REN Mei-ping;LI Rong;LI Mao;XIAO Shun-han
LIU Ming-hua;ZHANG Zhuo;REN Mei-ping;LI Rong;LI Mao;XIAO Shun-han
..............page:1899-1902
Pharmacology and clinical evaluation of Qutenza
HAN Ying;ZHU Yi;FU De-xing
HAN Ying;ZHU Yi;FU De-xing
..............page:1825-1827
yi gu li chuang xin wei he xin yin ling yao pin zhu ce guan li gong zuo
yang sheng xia jun ping zhang wei
yang sheng xia jun ping zhang wei
..............page:1828-1829,1846,1818
Clinical recommendation on promestriene （Colpotrophine） in vaginal estrogen therapy
Menopause Society;Obstetrics & Gynecology Affiliation;Chinese Medical Association
Menopause Society;Obstetrics & Gynecology Affiliation;Chinese Medical Association
..............page:1879-1880,1894
Correlation between in vivo absorption and in vitro release of cisplatin implants
WANG Shi-liang1;3;LIU Hua-ding2;YE Hong-yang3;XU Yuan-yuan4;DING Man-zhi3;CHU Cheng-ding3;4;XUAN Feng-qin1;3;FU Yan-hua1;3;ZHONG Jing1;3
WANG Shi-liang1;3;LIU Hua-ding2;YE Hong-yang3;XU Yuan-yuan4;DING Man-zhi3;CHU Cheng-ding3;4;XUAN Feng-qin1;3;FU Yan-hua1;3;ZHONG Jing1;3
..............page:1915-1920
Tumor-inhibiting effect of etoposide long-circulating liposomes
SHI Jun1;2;CHENG Yi1;CHEN Wei-hong1;LIN De-hui1
SHI Jun1;2;CHENG Yi1;CHEN Wei-hong1;LIN De-hui1
..............page:1881-1884
Enlightenment from the experiences on development model of India pharmaceutical industry in the perspective of global value chain
ZHENG Xiao-nan;HUANG Wen-long
ZHENG Xiao-nan;HUANG Wen-long
..............page:1847-1852,1878
Modulating effects of Ca2+ and syntaxin 1 on seronin transporter activity in the presynaptic membrane
LIU Zhi-jun1;2;ZHAO Ming1;CHEN Nai-hong1
LIU Zhi-jun1;2;ZHAO Ming1;CHEN Nai-hong1
..............page:1853-1858
The US FDA drug safety information disclosure and its implication
XU Lai1;2;YU Bo-yang1;YANG Yi-han2
XU Lai1;2;YU Bo-yang1;YANG Yi-han2
..............page:1841-1846